Can everyday moisturizers soothe cancer Therapy's skin toll?

NCT ID NCT07767448

NEW Not yet recruiting Symptom relief Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Aug 17, 2026 · Last updated Aug 17, 2026

Summary

This trial tests whether cosmeceutical moisturizers can ease skin dryness in people with cancer who experience skin side effects from treatments like chemotherapy or immunotherapy. Participants apply the moisturizers daily for 2-4 weeks and report changes in dryness severity. The goal is to see if these products provide a simple, supportive option for managing treatment-related skin discomfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cosmeceutical topical moisturizers (La Roche Posay Lipikar wash, cream, and Cicaplast balm)
What this could lead to: If effective, these moisturizers could offer a simple, non-drug way to ease skin dryness and improve comfort for people undergoing cancer therapy.
What could go wrong: This is a small, early study without a comparison group, so results may not be conclusive. The moisturizers may not work for everyone, and individual skin reactions can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Stanford Health Care: Supportive Dermato-Oncology Program

Palo Alto, California, 94304, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.